Evaluation of a Screening System for Obesogenic Compounds: Screening of Endocrine Disrupting Compounds and Evaluation of the PPAR Dependency of the Effect

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Pereira Fernandes, Anna ^a   Demaegdt, Heidi ^b   Vandermeiren, Karine ^b   Hectors, Tine L M ^a   Jorens, Philippe G ^a   Blust, Ronny ^a   Vanparys, Caroline ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b VETERINARY AND AGROCHEMICAL RESEARCH CENTRE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYBENZOIC ACID ESTER; 4,4' ISOPROPYLIDENEDIPHENOL; ALKYLPHENOL; DOMESTIC CHEMICAL; ENDOCRINE DISRUPTOR; LIPID; MUSK; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHTHALIC ACID; ROSIGLITAZONE; TRIBUTYLTIN;

ADIPOGENESIS; ANIMAL CELL; ARTICLE; CLASSIFICATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; HOUSEHOLD; LIPID STORAGE; MOUSE; NONHUMAN; OBESITY; POLLUTANT; RELIABILITY; SCREENING TEST; SENSITIVITY ANALYSIS; STANDARDIZATION;

3T3-L1 CELLS; ADIPOCYTES; ANIMALS; CELL DIFFERENTIATION; ENDOCRINE DISRUPTORS; INSULIN; MICE; OBESITY; PPAR GAMMA; REFERENCE STANDARDS; STAINING AND LABELING; TRANSCRIPTIONAL ACTIVATION;

EID: 84885409730     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0077481     Document Type: Article

References (55)

1. Zoeller RT, Brown TR, Doan LL, Gore AC, Skakkebaek NE, et al. (2012) Endocrine-disrupting chemicals and public health protection: a statement of principles from The Endocrine Society. Endocrinology 153: 4097-4110. doi:10.1210/en.2012-1422. PubMed: 22733974.
2. Casals-Casas C, Desvergne B, (2011) Endocrine disruptors: from endocrine to metabolic disruption. Annu Rev Physiol 73: 135-162. doi:10.1146/annurev-physiol-012110-142200. PubMed: 21054169.
3. Hectors TLM, Vanparys C, van der Ven K, Martens GA, Jorens PG, et al. (2011) Environmental pollutants and type 2 diabetes: a review of mechanisms that can disrupt beta cell function. Diabetologia 54: 1273-1290. doi:10.1007/s00125-011-2109-5. PubMed: 21442161.
4. Grün F, Watanabe H, Zamanian Z, Maeda L, Arima K, et al. (2006) Endocrine-disrupting organotin compounds are potent inducers of adipogenesis in vertebrates. Mol Endocrinol 20: 2141-2155. doi:10.1210/me.2005-0367. PubMed: 16613991.
5. Wang YF, Chao HR, Wu CH, Tseng CH, Kuo YT, et al. (2010) A recombinant peroxisome proliferator response element-driven luciferase assay for evaluation of potential environmental obesogens. Biotechnol Lett 32: 1789-1796. doi:10.1007/s10529-010-0359-9. PubMed: 20665227.
6. Taxvig C, Dreisig K, Boberg J, Nellemann C, Schelde AB, et al. (2012) Differential effects of environmental chemicals and food contaminants on adipogenesis, biomarker release and PPARgamma activation. Mol Cell Endocrinol 361: 106-115. doi:10.1016/j.mce.2012.03.021. PubMed: 22526026.
7. Sargis RM, Johnson DN, Choudhury RA, Brady MJ, (2010) Environmental Endocrine Disruptors Promote Adipogenesis in the 3T3-L1 Cell Line through Glucocorticoid Receptor Activation. Obesity 18: 1283-1288. doi:10.1038/oby.2009.419. PubMed: 19927138.
8. OECD (2012) DETAILED REVIEW PAPER ON THE STATE OF THE SCIENCE ON NOVEL IN VITRO AND IN VIVO SCREENING AND TESTING METHODS AND ENDPOINTS FOR EVALUATING ENDOCRINE DISRUPTORS. OECD Environment, Health and Safety Publications Series on Testing and Assessment. No. 178. Paris: Organisation for Economic Cooperation and Development. Available: http://search.oecd.org/officialdocuments/displaydocumentpdf/?cote=env/jm/mono. Retrieved onpublished at whilst December year 1111 from 2012)23&doclanguage=en. Accessed 2013 September 1.
9. Vanparys C, Maras M, Lenjou M, Robbens J, Van Bockstaele D, et al. (2006) Flow cytometric cell cycle analysis allows for rapid screening of estrogenicity in MCF-7 breast cancer cells. Toxicol Vitro 20: 1238-1248. doi:10.1016/j.tiv.2006.05.002. PubMed: 16797915.
10. Heudorf U, Mersch-Sundermann V, Angerer J, (2007) Phthalates: toxicology and exposure. Int J Hyg Environ Health 210: 623-634. doi:10.1016/j.ijheh.2007.07.011. PubMed: 17889607.
11. Bonefeld-Jørgensen EC, Long M, Hofmeister MV, Vinggaard AM, (2007) Endocrine-disrupting potential of bisphenol A, bisphenol A dimethacrylate, 4-n-nonylphenol, and 4-n-octylphenol in vitro: new data and a brief review. Environ Health Perspect 115 (Suppl 1):: 69-76. doi:10.1289/ehp.9368. PubMed: 18174953.
12. van Meeuwen JA, van Son O, Piersma AH, de Jong PC, van den Berg M, (2008) Aromatase inhibiting and combined estrogenic effects of parabens and estrogenic effects of other additives in cosmetics. Toxicol Appl Pharmacol 230: 372-382. doi:10.1016/j.taap.2008.03.002. PubMed: 18486175.
13. Müller S, Schmid P, Schlatter C, (1996) Occurrence of nitro and non-nitro benzenoid musk compounds in human adipose tissue. Chemosphere 33: 17-28. doi:10.1016/0045-6535(96)00160-9. PubMed: 8680828.
14. Kannan K, Reiner JL, Yun SH, Perrotta EE, Tao L, et al. (2005) Polycyclic musk compounds in higher trophic level aquatic organisms and humans from the United States. Chemosphere 61: 693-700. doi:10.1016/j.chemosphere.2005.03.041. PubMed: 16219504.
15. Rimkus GG, Wolf M, (1996) Polycyclic musk fragrances in human adipose tissue and human milk. Chemosphere 33: 2033-2043. doi:10.1016/0045-6535(96)00321-9. PubMed: 8930104.
16. Moon HB, Lee DH, Lee YS, Kannan K, (2011) Occurrence and accumulation patterns of polycyclic aromatic hydrocarbons and synthetic musk compounds in adipose tissues of Korean females. Chemosphere, 86: 485-90. PubMed: 22055311.
17. Schiavone A, Kannan K, Horii Y, Focardi S, Corsolini S, (2009) Polybrominated diphenyl ethers, polychlorinated naphthalenes and polycyclic musks in human fat from Italy: comparison to polychlorinated biphenyls and organochlorine pesticides. Environ Pollut 158: 599-606. PubMed: 19796858.
18. Aldridge A, Kouroupis D, Churchman S, English A, Ingham E, et al. (2013) Assay validation for the assessment of adipogenesis of multipotential stromal cells-a direct comparison of four different methods. Cytotherapy 15: 89-101. doi:10.1016/j.jcyt.2012.07.001. PubMed: 23260089.
19. Nociari MM, Shalev A, Benias P, Russo C, (1998) A novel one-step, highly sensitive fluorometric assay to evaluate cell-mediated cytotoxicity. J Immunol Methods 213: 157-167. doi:10.1016/S0022-1759(98)00028-3. PubMed: 9692848.
20. Li X, Ycaza J, Blumberg B, (2011) The environmental obesogen tributyltin chloride acts via peroxisome proliferator activated receptor gamma to induce adipogenesis in murine 3T3-L1 preadipocytes. J Steroid Biochem Mol Biol 127: 9-15. doi:10.1016/j.jsbmb.2011.03.012. PubMed: 21397693.
21. Pereira-Fernandes A, Vanparys C, Hectors TL, Vergauwen L, Knapen D, et al. (2013) Unraveling the mode of action of an obesogen: Mechanistic analysis of the model obesogen tributyltin in the 3T3-L1 cell line. Mol Cell Endocrinol, 370: 52-64. PubMed: 23428407.
22. Pereira-Fernandes A, Vanparys C, Hectors TL, Vergauwen L, Knapen D, et al. (2013) Unraveling the mode of action of an obesogen: Mechanistic analysis of the model obesogen tributyltin in the 3T3-L1 cell line. Mol Cell Endocrinol 370: 52-64. doi:10.1016/j.mce.2013.02.011. PubMed: 23428407.
23. Hassan M, El Yazidi C, Landrier JF, Lairon D, Margotat A, et al. (2007) Phloretin enhances adipocyte differentiation and adiponectin expression in 3T3-L1 cells. Biochem Biophys Res Commun 361: 208-213. doi:10.1016/j.bbrc.2007.07.021. PubMed: 17658475.
24. Petersen RK, Madsen L, Pedersen LM, Hallenborg P, Hagland H, et al. (2008) Cyclic AMP (cAMP)-mediated stimulation of adipocyte differentiation requires the synergistic action of Epac- and cAMP-dependent protein kinase-dependent processes. Mol Cell Biol 28: 3804-3816. doi:10.1128/MCB.00709-07. PubMed: 18391018.
25. Pfaffl MW, (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29: e45. doi:10.1093/nar/29.9.e45. PubMed: 11328886.
26. Armbruster DA, Tillman MD, Hubbs LM, (1994) Limit of detection (LQD)/limit of quantitation (LOQ): comparison of the empirical and the statistical methods exemplified with GC-MS assays of abused drugs. Clin Chem 40: 1233-1238. PubMed: 8013092.
27. Zhang XD, (2007) A new method with flexible and balanced control of false negatives and false positives for hit selection in RNA interference high-throughput screening assays. J Biomol Screen 12: 645-655. doi:10.1177/1087057107300645. PubMed: 17517904.
28. Zhang XD, (2007) A pair of new statistical parameters for quality control in RNA interference high-throughput screening assays. Genomics 89: 552-561. doi:10.1016/j.ygeno.2006.12.014. PubMed: 17276655.
29. Grün F, Blumberg B, (2009) Endocrine disrupters as obesogens. Mol Cell Endocrinol 304: 19-29. doi:10.1016/j.mce.2009.02.018. PubMed: 19433244.
30. Holtcamp W, (2012) Obesogens: an environmental link to obesity. Environ Health Perspect 120: a62-a68. doi:10.1289/ehp.120-a62. PubMed: 22296745.
31. Li X, Pham HT, Janesick AS, Blumberg B, (2012) Triflumizole is an obesogen in mice that acts through peroxisome proliferator activated receptor gamma (PPARgamma). Environ Health Perspect 120: 1720-1726. PubMed: 23086663.
32. Masuno H, Kidani T, Sekiya K, Sakayama K, Shiosaka T, et al. (2002) Bisphenol A in combination with insulin can accelerate the conversion of 3T3-L1 fibroblasts to adipocytes. J Lipid Res 43: 676-684. PubMed: 11971937.
33. Larsen TM, Toubro S, Astrup A, (2003) PPARgamma agonists in the treatment of type II diabetes: is increased fatness commensurate with long-term efficacy? Int J Obes Relat Metab Disord 27: 147-161. doi:10.1038/sj.ijo.802223. PubMed: 12586994.
34. Vanparys C, Depiereux S, Nadzialek S, Robbens J, Blust R, et al. (2010) Performance of the flow cytometric E-screen assay in screening estrogenicity of pure compounds and environmental samples. Sci Total Environ 408: 4451-4460. doi:10.1016/j.scitotenv.2010.06.049. PubMed: 20633926.
35. Delgado-Saborit JM, Stark C, Harrison RM, (2011) Carcinogenic potential, levels and sources of polycyclic aromatic hydrocarbon mixtures in indoor and outdoor environments and their implications for air quality standards. Environ Int 37: 383-392. doi:10.1016/j.envint.2010.10.011. PubMed: 21146218.
36. Janesick A, Blumberg B, (2011) Minireview: PPAR gamma as the target of obesogens. J Steroid Biochem Mol Biol 127: 4-8. doi:10.1016/j.jsbmb.2011.01.005. PubMed: 21251979.
37. Harvey PW, Everett DJ, (2006) Regulation of endocrine-disrupting chemicals: critical overview and deficiencies in toxicology and risk assessment for human health. Best Pract Res Clin Endocrinol Metab 20: 145-165. doi:10.1016/j.beem.2005.09.008. PubMed: 16522525.
38. Harvey PW, Darbre P, (2004) Endocrine disrupters and human health: Could oestrogenic chemicals in body care cosmetics adversely affect breast cancer incidence in women? A review of evidence and call for further research. J Appl Toxicol 24: 167-176. doi:10.1002/jat.978. PubMed: 15211609.
39. OSPAR (2004) Musk xylene and other musks. Oslo and Paris Convention for the Protection of the Marine Environment of the North-East Atlantic.
40. Hao C, Cheng X, Guo J, Xia H, Ma X, (2013) Perinatal exposure to diethyl-hexyl-phthalate induces obesity in mice. Front Biosci (Elite Ed) 5: 725-733.
41. Feige JN, Gelman L, Rossi D, Zoete V, Métivier R, et al. (2007) The endocrine disruptor monoethyl-hexyl-phthalate is a selective peroxisome proliferator-activated receptor gamma modulator that promotes adipogenesis. J Biol Chem 282: 19152-19166. doi:10.1074/jbc.M702724200. PubMed: 17468099.
42. Hurst CH, Waxman DJ, (2003) Activation of PPARalpha and PPARgamma by environmental phthalate monoesters. Toxicol Sci 74: 297-308. doi:10.1093/toxsci/kfg145. PubMed: 12805656.
43. Hatch EE, Nelson JW, Qureshi MM, Weinberg J, Moore LL, et al. (2008) Association of urinary phthalate metabolite concentrations with body mass index and waist circumference: a cross-sectional study of NHANES data, 1999-2002. Environ Health 7: 27. doi:10.1186/1476-069X-7-27. PubMed: 18522739.
44. Desvergne B, Feige JN, Casals-Casas C, (2009) PPAR-mediated activity of phthalates: A link to the obesity epidemic? Mol Cell Endocrinol 304: 43-48. doi:10.1016/j.mce.2009.02.017. PubMed: 19433246.
45. Boberg J, Metzdorff S, Wortziger R, Axelstad M, Brokken L, et al. (2008) Impact of diisobutyl phthalate and other PPAR agonists on steroidogenesis and plasma insulin and leptin levels in fetal rats. Toxicology 250: 75-81. doi:10.1016/j.tox.2008.05.020. PubMed: 18602967.
46. Kanayama T, Kobayashi N, Mamiya S, Nakanishi T, Nishikawa J, (2005) Organotin compounds promote adipocyte differentiation as agonists of the peroxisome proliferator-activated receptor gamma/retinoid x receptor pathway. Mol Pharmacol 67: 766-774. PubMed: 15611480.
47. Masuno H, Iwanami J, Kidani T, Sakayama K, Honda K, (2005) Bisphenol a accelerates terminal differentiation of 3T3-L1 cells into adipocytes through the phosphatidylinositol 3-kinase pathway. Toxicol Sci 84: 319-327. doi:10.1093/toxsci/kfi088. PubMed: 15659569.
48. Rubin BS, Murray MK, Damassa DA, King JC, Soto AM, (2001) Perinatal exposure to low doses of bisphenol A affects body weight, patterns of estrous cyclicity, and plasma LH levels. Environ Health Perspect 109: 675-680. doi:10.1289/ehp.01109675. PubMed: 11485865.
49. Masuno H, Okamoto S, Iwanami J, Honda K, Shiosaka T, et al. (2003) Effect of 4-nonylphenol on cell proliferation and adipocyte formation in cultures of fully differentiated 3T3-L1 cells. Toxicol Sci 75: 314-320. doi:10.1093/toxsci/kfg203. PubMed: 12883076.
50. Witorsch RJ, Thomas JA, (2010) Personal care products and endocrine disruption: A critical review of the literature. Crit Rev Toxicol 40 (Suppl 3):: 1-30. doi:10.3109/10408440903300098. PubMed: 20932229.
51. Hu P, Chen X, Whitener RJ, Boder ET, Jones JO, et al. (2012) Effects of Parabens on Adipocyte Differentiation. Toxicol Sci, 131: 56-70. PubMed: 22956630.
52. McKim JM Jr., (2010) Building a tiered approach to in vitro predictive toxicity screening: a focus on assays with in vivo relevance. Comb Chem High Throughput Screen 13: 188-206. doi:10.2174/138620710790596736. PubMed: 20053163.
53. Janderová L, McNeil M, Murrell AN, Mynatt RL, Smith SR, (2003) Human mesenchymal stem cells as an in vitro model for human adipogenesis. Obes Res 11: 65-74. doi:10.1038/oby.2003.11. PubMed: 12529487.
54. Phinney DG, Kopen G, Righter W, Webster S, Tremain N, et al. (1999) Donor variation in the growth properties and osteogenic potential of human marrow stromal cells. J Cell Biochem 75: 424-436. doi:10.1002/(SICI)1097-4644(19991201)75:3. PubMed: 10536366.
55. Sen A, Lea-Currie YR, Sujkowska D, Franklin DM, Wilkison WO, et al. (2001) Adipogenic potential of human adipose derived stromal cells from multiple donors is heterogeneous. J Cell Biochem 81: 312-319. doi:10.1002/1097-4644(20010501)81:2. PubMed: 11241671.